CLDF-GHAPP Podcast Series: MASH
4 Part Series
Hosted by: Nadege Gunn, MD
With Special Guests: Elizabeth Goacher, PA, and Ann Moore, NP
Related Podcast
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2025
GHAPPcast: Recognizing the Severity of MASH
2025
Part 3 - Strategies for Educating the APP Community on MASH
2024
What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?
2025
What is MASH?
2025
Part 2 - Using NITs to Identify and Manage MASH Patients
2024
Key Takeaways - Major Advancements In The Management of MASH with Parvez, Mantry, MD
2024
Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice
2024
What Are the Consequences of MASH Going Untreated?
2025
What Is Resmetirom and How Does It Work to Treat MASH?
2025